Phase II Study of Niraparib and Dostarlimab With Radiation in Patients With Metastatic Pancreatic Cancer
Summary
The purpose of this phase II study is to evaluate the safety and efficacy of niraparib with dostarlimab and radiation therapy in patients with metastatic pancreatic cancer.
General Information
NCT#: NCT04409002
Study ID: 19-538
Trial Phase: Phase II
Trial Sponsor: Massachusetts General Hospital, Tesaro
Therapies Used in This Trial: Radiation Therapy, Niraparib, Dostarlimab